This announcement is a separate document:
罗欣药业:关于更换重大资产重组独立财务顾问主办人的公告
Luoxin Pharmaceuticals Group Stock: Announcement Regarding Replacement of Independent Financial Advisor and Sponsor for Major Asset Restructuring.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.